Risk for colon cancer appears to be associated with increased and abnormal colonic epithelial cell proliferation. Extensive laboratory experimentation has demonstrated that the process of carcinogenesis in many organs, including the colon, is dependent on intact activity of the enzyme ornithine decarboxylase (ODC) and subsequent synthesis of polyamines. Inhibition of this biochemical pathway with DFMO blocks the development of tumors in nearly all animal models tested, including specific chemically- induced tumors of the colon. We there fore plan to test the efficacy of DFMO in modulating measures of polyamine synthesis (ODC activity, polyamine content) and epithelial cell proliferation (crypt [3H] thymidine labeling) for rectal mucosal biopsies. Patients between the ages of 40 and 80 who have had a colon polyp removed in the prior 3 months will be the subject population. Two major trials will be sequentially conducted. In the first study the initial group of 10 subjects will received a dose of DFMO which would be regarded as the highest desirable in a chemoprevention trial. The drug will be given for one months and the level of polyamine synthesis and cellular proliferation measured in rectal mucosal biopsies pre and post treatment. The dose of DFMO will be decreased in each subsequent group of 10 patients until no effect on polyamine synthesis and cellular proliferation is demonstrated. A dose at which 25% inhibition of these biochemical markers is consistently seen will be used for a longer term phase IIb trial. In this study, 100 patients will be randomly assigned to placebo and DFMO groups and the effects on biochemical markers measured over a two year period. The effects on the indicated biochemical parameters in the rectal mucosal biopsies will be correlated to levels of polyamine synthesis in other more easily accessible tissues, including epithelial cells from the buccal mucosal and buffy coat leukocytes. Serum DFMO levels will be used as a marker of dosing compliance as well. The demonstration of consistent inhibition of polyamine synthesis and cellular proliferation in the treatment group will serve as the basis for planning a subsequent randomized, placebo-controlled will serve as the basis for planning a subsequent randomized, placebo-controlled phase III prevention trial in which colon polyp recurrence will serve as a surrogate indicator of colon cancer risk.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA041108-08
Application #
3750607
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
8
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of Arizona
Department
Type
DUNS #
City
Tucson
State
AZ
Country
United States
Zip Code
85721
Lance, Peter; Alberts, David S; Thompson, Patricia A et al. (2017) Colorectal Adenomas in Participants of the SELECT Randomized Trial of Selenium and Vitamin E for Prostate Cancer Prevention. Cancer Prev Res (Phila) 10:45-54
Thompson, Patricia A; Ashbeck, Erin L; Roe, Denise J et al. (2016) Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes. J Natl Cancer Inst 108:
Jacobs, Elizabeth T; Haussler, Mark R; Alberts, David S et al. (2016) Association between Circulating Vitamin D Metabolites and Fecal Bile Acid Concentrations. Cancer Prev Res (Phila) 9:589-97
Liu, Lin; Messer, Karen; Baron, John A et al. (2016) A prognostic model for advanced colorectal neoplasia recurrence. Cancer Causes Control 27:1175-85
Thompson, Patricia A; Ashbeck, Erin L; Roe, Denise J et al. (2016) Celecoxib for the Prevention of Colorectal Adenomas: Results of a Suspended Randomized Controlled Trial. J Natl Cancer Inst 108:
Hibler, Elizabeth A; Sardo Molmenti, Christine L; Dai, Qi et al. (2016) Physical activity, sedentary behavior, and vitamin D metabolites. Bone 83:248-255
Hibler, Elizabeth A; Klimentidis, Yann C; Jurutka, Peter W et al. (2015) CYP24A1 and CYP27B1 Polymorphisms, Concentrations of Vitamin D Metabolites, and Odds of Colorectal Adenoma Recurrence. Nutr Cancer 67:1131-41
Minasian, Lori M; Tangen, Catherine M; Wickerham, D Lawrence (2015) Ongoing Use of Data and Specimens From National Cancer Institute-Sponsored Cancer Prevention Clinical Trials in the Community Clinical Oncology Program. Semin Oncol 42:748-63
Bea, Jennifer W; Jurutka, Peter W; Hibler, Elizabeth A et al. (2015) Concentrations of the vitamin D metabolite 1,25(OH)2D and odds of metabolic syndrome and its components. Metabolism 64:447-59
Molmenti, Christine L Sardo; Hibler, Elizabeth A; Ashbeck, Erin L et al. (2014) Sedentary behavior is associated with colorectal adenoma recurrence in men. Cancer Causes Control 25:1387-95

Showing the most recent 10 out of 149 publications